These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 13380265)

  • 1. [Inhibition of neutralizing power of anti-poliomyelitis serum and action of inactivated virus].
    INSERILLO G; ODDO FG
    Riv Ist Sieroter Ital; 1956; 31(3):185-6. PubMed ID: 13380265
    [No Abstract]   [Full Text] [Related]  

  • 2. [Control of the antigenic power of vaccine for poliomyelitis prepared with inactivated virus].
    CASTELLI L; BALDUCCI D; MANCINI G; PAULUZZI S
    Riv Ist Sieroter Ital; 1960; 35():529-38. PubMed ID: 13691408
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on poliomyelitis virus. II. The immunogenic potency of live and inactivated virus in guinea-pigs.
    HAMPTON JW; POLSON A; SELZER G
    J Hyg (Lond); 1958 Jun; 56(2):260-5. PubMed ID: 13563867
    [No Abstract]   [Full Text] [Related]  

  • 4. [First results of human antipoliomyelitis vaccination with vaccine prepared with the Salk type of inactivated virus].
    SANTOPADRE G
    Nuovi Ann Ig Microbiol; 1959; 10():359-61. PubMed ID: 14441610
    [No Abstract]   [Full Text] [Related]  

  • 5. [Complement fixing antibodies after vaccination with inactivated polio virus].
    LENNARTZ H; HERTENSTEIN C; CRUESEMANN R
    Klin Wochenschr; 1959 Dec; 37():1261-2. PubMed ID: 14415702
    [No Abstract]   [Full Text] [Related]  

  • 6. [Sero-neutralizing antibodies against poliomyelitis virus II (Lansing) in inhabitants of Bucharest].
    CAJAL N; LISSIEVICI-OPRESCU E
    Stud Cercet Inframicrobiol; 1956; 7(1-2):57-63. PubMed ID: 13380643
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immune tolerance in the white rat to the inactivated type 2 poliomyelitis virus. II].
    GALLO E; FARISANO G; GASPARINI V
    Boll Ist Sieroter Milan; 1962; 41():215-20. PubMed ID: 13896466
    [No Abstract]   [Full Text] [Related]  

  • 8. The titration of poliomyelitis neutralizing antibodies.
    PERKINS FT; SOUSA CA; TOBIN JO
    Br J Exp Pathol; 1958 Apr; 39(2):171-7. PubMed ID: 13523072
    [No Abstract]   [Full Text] [Related]  

  • 9. Present status of immunization against poliomyelitis (Salk vaccine versus living, attenuated virus).
    WEISS C
    J Albert Einstein Med Cent (Phila); 1956 Sep; 4(4):159-60. PubMed ID: 13357446
    [No Abstract]   [Full Text] [Related]  

  • 10. Placental transmission of neutralizing antibodies to poliomyelitis virus.
    Agarwal SC; Bardoloi JN; Sehgal S; Gupta AN
    Indian J Med Res; 1971 Nov; 59(11):1703-7. PubMed ID: 4335246
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of different methods of neutralizing antibodies estimation in poliomyelitis.
    VONKA V; ZACEK K
    J Hyg Epidemiol Microbiol Immunol; 1961; 5():168-77. PubMed ID: 13782084
    [No Abstract]   [Full Text] [Related]  

  • 12. The development of homologous neutralizing antibody during a type 1 poliomyelitis epidemic.
    MILES JA; AUSTIN FJ; CAUGHEY JE
    J Hyg (Lond); 1958 Sep; 56(3):347-54. PubMed ID: 13587984
    [No Abstract]   [Full Text] [Related]  

  • 13. [Study of neutralizing antibodies of poliomyelitis among the Africans (Negroes and pygmies) of the Belgian Congo].
    BARSKI G; LEPINE P
    Bull World Health Organ; 1956; 14(1):119-28. PubMed ID: 13329841
    [No Abstract]   [Full Text] [Related]  

  • 14. A study of the occurrence of poliomyelitis and of neutralizing antibodies against the three types of poliomyelitis virus in Finland.
    LAPINLEIMU K
    Ann Med Exp Biol Fenn; 1956; 34(Suppl 11):1-104. PubMed ID: 13444873
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunological studies in poliomyelitis. II. Preliminary results on research of neutralizing antibodies in two school groups at the end of an epidemic].
    DEBRE R; CELERS J; DROUHET V; SOULE JL
    Rev Immunol Ther Antimicrob; 1957; 21(3):119-35. PubMed ID: 13466680
    [No Abstract]   [Full Text] [Related]  

  • 16. [Isolation of poliomyelitis virus and serological investigations in cases of paralytic poliomyelitis occurring in Palermo in 1954].
    ODDO FG
    Riv Ist Sieroter Ital; 1955; 30(4):217-27. PubMed ID: 13281358
    [No Abstract]   [Full Text] [Related]  

  • 17. [Preparation and control of the Salk vaccine against poliomyelitis].
    DE SOMER P
    Belg Tijdschr Geneesk; 1956 Aug; 12(16):841-52. PubMed ID: 13355838
    [No Abstract]   [Full Text] [Related]  

  • 18. Vaccination against poliomyelitis with live virus vaccines. II. A trial of SM type I attenuated poliomyelitis virus vaccine.
    CONNOLLY JH; DANE DS; DICK GW; FISHER OD; MCKEOWN F
    Br Med J; 1957 Jan; 1(5010):65-70. PubMed ID: 13383194
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative results of serum neutralizations and titers of the poliomyelitis virus executed by micromethod on plastic plates and by the classical tube method].
    BARSKI G; CORNEFERT F; LEPINE P
    Ann Inst Pasteur (Paris); 1956 Oct; 91(4):427-35. PubMed ID: 13373062
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on the epidemiology of poliomyelitis in New Zealand. II. Neutralising antibodies present in the sera of 144 adults.
    MURPHY AM
    N Z Med J; 1956 Aug; 55(308):278-81. PubMed ID: 13369812
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.